Mabion extended the scope of its cooperation with US Novavax to add another possible product to be produced by Mabion, namely Covid vaccine antigen for Omicron variant. The number of series of Omicron product will be agreed upon on the fly, with the manufacturing slots guaranteed to Novavax based on the contract between the two firms.